65 Days
Source:
الوسط
Amir Sheikh Mishal Meets New Ministers
Reports indicate that the American pharmaceutical company Pfizer is aiming to increase its COVID-19 vaccine sales to nearly $35 billion by 2026, amid expectations of raising prices by up to four times. This increase would be one of the largest in the company's history. The move is part of a strategy to boost profits from the vaccine after demand for medicines declined over the past few years. The company plans to introduce new vaccines and expand its marketing efforts in global markets to achieve its financial objectives.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)